Pura Scents Recalling More Than 850,000 Diffuser Covers as Magnet Issue May Cause Ingestion Hazard
The company is recalling the detachable covers for about 851,400 Pura 4 Smart Home Fragrance Diffusers. It said an additional 1,100 were sold in Canada.
Pura Scents said that the magnets on the inside cover of the product can detach, posing an ingestion hazard to children. When high-powered magnets are swallowed, the ingested magnets can attract each other, or other metal objects, and become lodged in the digestive system. This can result in perforations, twisting or blockage of the intestines, infection, blood poisoning and death.
Story continues below advertisement
The company has received three reports of magnets detaching from the cover. No injuries have been reported.
The diffusers were sold at Target, Scheels and other stores nationwide from August 2023 through May 2025 for about $50. They were also sold online through Pura's website, as well as online at Amazon, Target and Scheels.
Pura Scents is offering a free replacement cover. Consumers are advised to immediately dispose of the existing detachable cover and to keep the diffusers out of the reach of children and pets.
To receive the free replacement cover, individuals may contact Pura Scents at 855-394-5292 from 9 a.m. to 5 p.m. MT Monday through Friday. The company can also be emailed at replacement@pura.com. Consumers may also visit the company's website and click on 'Recall' at the bottom of the page for more information.
By Michelle Chapman
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
a day ago
- Newsweek
Nationwide Recall for Product Sold at Target, Amazon: Dispose 'Immediately'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. More than 800,000 home fragrance diffusers sold at major outlets nationwide have been recalled due to concerns that the product poses a serious choking hazard to children. Pura Scents issued a nationwide recall of its Pura 4 Smart Home Fragrance with detachable covers after reports surfaced that magnets inside the covers can detach. The recall, effective July 24, affects approximately 851,400 units sold in the United States and an additional 1,100 units in Canada. The products were available through major retailers, including Target, Amazon, Scheels, and others, from August 2023 through May 2025 and retailed for $50, according to the Consumer Product Safety Commission (CPSC). Newsweek reached out to Pura Scents' general support department and its cofounder via email on Monday for comment. The recalled Pura 4 Smart Home Fragrance Diffusers. The recalled Pura 4 Smart Home Fragrance Diffusers. cpsc Why It Matters The recall highlighted critical child safety issues with products commonly found in U.S. homes. "When high-powered magnets are swallowed, the ingested magnets can attract each other, or other metal objects, and become lodged in the digestive system. This can result in perforations, twisting and/or blockage of the intestines, infection, blood poisoning and death," the CPSC said in an alert on the recall. This recall follows a series of other recent product recalls at major U.S. retailers, including Target, involving food items, nursery furniture, and additional home goods, underscoring ongoing risks for American consumers and the importance of prompt recall compliance. What To Know The recall pertains to Pura 4 Smart Home Fragrance Diffusers with detachable covers containing five internal magnets—three small and two larger ones. Serial numbers for affected units range from JX230000001 to JX230801425 and JX240000001 to JX240049959, as printed on the rear label above the metal prongs. The 4-inch-by-4-inch diffusers were imported by Pura Scents Inc. and manufactured in China. Pura Scents received three reports of magnets detaching from the cover. As of the recall date, no injuries were reported. Customers who purchased these devices through or in-store locations are instructed to remove and dispose of the detachable cover immediately, keep the device away from children and pets, and contact Pura for a free replacement cover. The company said it is proactively contacting all known purchasers directly. Consumers should phone Pura Scents toll-free at 855-394-5292 (Monday–Friday, 9 a.m.–5 p.m. MT), email replacement@ or visit Pura's product recall site for more details and to request a replacement front cover. Additional guidance explains how to safely dispose of the original detachable covers while awaiting replacements. This recall comes amid a spate of product recalls affecting Target and similar retailers in 2025. Recent examples include the recall of YoCrunch Yogurts for plastic contamination, RITZ Peanut Butter Cracker Sandwiches for allergen mislabeling, and Oscar Mayer Turkey Bacon for potential Listeria contamination. What People Are Saying Consumer Product Safety Commission's recall announcement on July 24 said: "Consumers should immediately remove the detachable covers from the recalled diffusers, dispose of the covers out of reach of children and pets, and contact Pura Scents to receive a free replacement front cover." What Happens Next Pura Scents is distributing free replacement covers to impacted customers and has pledged to continue outreach until all defective products are addressed. Consumers are advised to monitor the CPSC recall portal and company communications for updates.
Medscape
2 days ago
- Medscape
Secukinumab in Early PsA Starts Fast vs Standard of Care
TOPLINE: More patients with recently diagnosed psoriatic arthritis (PsA) saw clinical improvement by 3 months in a treat-to-target strategy with secukinumab, a monoclonal antibody targeting interleukin-17, compared with those on standard-of-care treatment, but this difference was not seen at later 3-month intervals out to 1 year. METHODOLOGY: In a randomized, open-label, manufacturer-sponsored, multicenter trial, 120 patients (mean age, 49; 41% women) diagnosed with PsA within the prior 3 months were randomized to a treat-to-target approach of early treatment with secukinumab or standard of care in which treatment escalated according to predetermined steps if patients failed to respond. At the start, in the secukinumab arm, 60 patients received 300 mg monthly secukinumab, a single injection of 80 mg triamcinolone, and 15 mg/wk methotrexate plus 10 mg/wk folic acid. In the standard-of-care arm, 60 patients received 80 mg triamcinolone (single injection), methotrexate starting at 15 mg/wk and increasing to 25 mg/wk by 6 weeks, and 10 mg/wk folic acid. In the standard-of-care arm, treatment was escalated by adding sulfasalazine 1000 mg twice daily if needed, then switching if needed to a first or second TNF inhibitor with methotrexate. In the secukinumab arm, patients with poor response were escalated to a TNF inhibitor with 25 mg methotrexate per week, followed by a second TNF inhibitor plus methotrexate if needed. Outcomes were measured at 3, 6, 9, and 12 months, and the primary endpoint was the percentage of patients achieving 50% or greater improvement in American College of Rheumatology response criteria (ACR50) at 6 months. TAKEAWAY: At 6 months, both trial arms had similar ACR50 rates (around 41% in the secukinumab arm vs 37% in the standard-of-care arm). However, first-line secukinumab was associated with significantly more patients achieving ACR50 at 3 months (about 42% vs 22%; P < .05). Secondary endpoints of the percentage of patients meeting criteria for Minimal Disease Activity, 90% improvement in Psoriasis Area Severity Index, and resolution of enthesitis and dactylitis generally followed the same pattern of quicker responses in the secukinumab arm, followed by numerically greater but not statistically significant differences in the secukinumab vs standard-of-care arms at later timepoints. IN PRACTICE: 'Early response is very important to patients. They don't necessarily care whether they are eventually going to catch up. They want to know they'll feel much better at 3 months,' commented Dafna Gladman, MD, senior scientist at the Toronto Western Research Institute and professor in the Institute of Medical Science at the University of Toronto, both in Toronto, Ontario, Canada. She was not a part of the study. SOURCE: Gonul Hazal Koc, MD, of Erasmus MC in Rotterdam, the Netherlands, led the research and presented the 12-month results in a poster at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Annual Meeting and Trainee Symposium in Bogotá, Colombia. LIMITATIONS: The study was not blinded, and a treat-to-target approach, while recommended by several guidelines, does not necessarily represent routine clinical practice in PsA. DISCLOSURES: Koc and her colleagues' research was supported by an unrestricted grant to her institution by Novartis, the manufacturer of secukinumab, which also supplied the study reported having no financial relationships outside the grant to her institution. Gladman has received research support and/or consultant fees from AbbVie, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly, Fresenius Kabi, Novartis, Galapagos, UCB, Gilead, Janssen, Roche, and Pfizer.
Epoch Times
3 days ago
- Epoch Times
Pura Scents Recalling More Than 850,000 Diffuser Covers as Magnet Issue May Cause Ingestion Hazard
Pura Scents is recalling more than 850,000 diffuser covers because some magnets may detach and cause a possible ingestion hazard to children. The company is recalling the detachable covers for about 851,400 Pura 4 Smart Home Fragrance Diffusers. It said an additional 1,100 were sold in Canada. Pura Scents said that the magnets on the inside cover of the product can detach, posing an ingestion hazard to children. When high-powered magnets are swallowed, the ingested magnets can attract each other, or other metal objects, and become lodged in the digestive system. This can result in perforations, twisting or blockage of the intestines, infection, blood poisoning and death. Story continues below advertisement The company has received three reports of magnets detaching from the cover. No injuries have been reported. The diffusers were sold at Target, Scheels and other stores nationwide from August 2023 through May 2025 for about $50. They were also sold online through Pura's website, as well as online at Amazon, Target and Scheels. Pura Scents is offering a free replacement cover. Consumers are advised to immediately dispose of the existing detachable cover and to keep the diffusers out of the reach of children and pets. To receive the free replacement cover, individuals may contact Pura Scents at 855-394-5292 from 9 a.m. to 5 p.m. MT Monday through Friday. The company can also be emailed at replacement@ Consumers may also visit the company's website and click on 'Recall' at the bottom of the page for more information. By Michelle Chapman
